News

Fennec Pharmaceuticals Highlights Participation at Key Healthcare Conference

Fennec Pharmaceuticals Highlights Participation at Key Healthcare Conference

Fennec Pharmaceuticals Participating in Healthcare Conference

In a significant announcement, Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a leader in specialty pharmaceutical innovations, has confirmed its participation in an engaging and insightful fireside chat as part of the Piper Sandler 37th Annual Healthcare Conference. This event is set to take place on December 3, 2025, at 1:00 p.m. Eastern Time and will be accessible via webcast.

Details of the Event

As the healthcare community eagerly anticipates this annual conference, Fennec is delighted to share more about the focus areas during this session. This includes their advancements in combating ototoxicity, an unfortunate side effect experienced by cancer patients undergoing cisplatin chemotherapy.

Webcast Information

For those interested in tuning in, the live webcast provides a wonderful opportunity to connect with the latest developments directly from Fennec Pharmaceuticals. Details for the webcast are as follows:

  • Date: Wednesday, December 3, 2025
  • Time: 1:00 p.m. Eastern Time

Participants can view the live session via the company’s dedicated events page, ensuring that those unable to attend in person can still engage with the discussions.

About Fennec Pharmaceuticals

Fennec Pharmaceuticals is on a crucial journey in the pharmaceutical landscape, dedicated to addressing the challenges posed by cisplatin-induced ototoxicity in cancer patients. Their heroic effort is centered around the commercialization of PEDMARK, a treatment specifically designed to reduce this risk, enhancing the quality of life for patients undergoing chemotherapy.

PEDMARK’s notable advances have made headlines with its FDA approval in 2022, followed by subsequent approvals in Europe and the United Kingdom. Brandishing the name PEDMARQSI in European markets, this therapy has become a beacon of hope for many.

The Licensing Agreement

In a bold move to expand its reach, Fennec has entered an exclusive licensing agreement with Norgine Pharmaceuticals Ltd. This partnership facilitates the commercialization of PEDMARQSI across Europe, the U.K., Australia, and New Zealand. As a result, the product is now available commercially in a select number of countries including the U.K. and Germany, marking a significant milestone in their growth journey.

Intellectual Property and Compliance

Fennec holds Orphan Drug Exclusivity for PEDMARK in the U.S. and has obtained Pediatric Use Marketing Authorization for PEDMARQSI in Europe, ensuring a robust level of market protection which spans a minimum of ten years. Additionally, the company is fortified with patents granting protection until 2039 in both the U.S. and internationally, securing their investment in ongoing research and development.

Staying Connected

Fennec Pharmaceuticals encourages stakeholders and interested parties to stay updated by visiting their official website and following them on social media platforms such as LinkedIn. Keeping abreast of news and updates from Fennec enables investors and patients alike to stay engaged with their journey and advancements in oncology.

Contact Information for Queries

If you have questions about Fennec Pharmaceuticals or seek more detailed insights, please reach out to:

Investors:
Robert Andrade
Chief Financial Officer
Fennec Pharmaceuticals Inc.
+1 919-246-5299

Corporate and Media:
Lindsay Rocco
Elixir Health Public Relations
+1 862-596-1304
lrocco@elixirhealthpr.com

Frequently Asked Questions

What is Fennec Pharmaceuticals known for?

Fennec Pharmaceuticals is recognized for its innovative treatments aimed at reducing cisplatin-induced ototoxicity in cancer patients.

When is the Piper Sandler Healthcare Conference?

The conference will take place on December 3, 2025, at 1:00 p.m. Eastern Time.

How can I access the webcast?

The live webcast can be accessed through Fennec Pharmaceuticals' events page.

What is PEDMARK?

PEDMARK is Fennec's flagship product designed to minimize the risk of hearing loss in cancer patients undergoing cisplatin-based chemotherapy.

Who can I contact for more information about Fennec?

You can contact Robert Andrade, CFO, or Lindsay Rocco from Elixir Health Public Relations for further inquiries.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Sacrifice Unending: 9/11's Lingering Health Toll

Updated Category News Views 1

The Unseen Toll of 9/11 on the Firefighter Community Two and a half decades since that fateful morning of September 11, 2001, we're staring at a grim reality. The heroic souls of the New York City Fire Department (FDNY)—those who ran toward peril when others ran away—are still paying the price. Incredibly, more than 400 FDNY members have succumbed to World Trade...

Continue Reading
Agroz's Big Leap: New Supply Deal in Malaysia

Updated Category News Views 3

Agroz Inc. Executes a Game-Changing Deal If anyone thought the ag tech players were sitting idle, think again. Agroz Inc., noted for their innovative controlled-environment agriculture, just inked a pivotal deal with Harvest Hive in Malaysia. It's not just a nod to expansion—it's a strategic leap into the big leagues. Picture this: Harvest Hive's sprawling 500-acre farm...

Continue Reading
ZEEKR's Shooting Brakes Dominate: Over 400K Sold

Updated Category News Views 4

ZEEKR's Stellar Performance in a Crowded Market Another month, another bumper crop for ZEEKR's shooting brakes. These beauties aren't just hanging in there; they're leading the pack. In August alone, global deliveries marched past the 10,000 mark for the third month running—a feat not easily achieved in today's saturated automotive landscape. It's no wonder the...

Continue Reading
Give Lively & Change Simplify CA Nonprofit Compliance

Updated Category News Views 1

A Fresh Wind Blowing for California Nonprofits So, here's a twist in the nonprofit world that's stirring the pot just right. Give Lively and Change have partnered up to tackle the thorny issue of regulatory compliance in California. It's a big win for the nonprofits looking to keep fundraising through Give Lively without getting tangled in the bureaucratic web spun up by...

Continue Reading
Are FULC, WEAV, TECH Shareholders Getting a Raw Deal?

Updated Category News Views 4

Pocketing Insider Gains Amidst Shareholder Concerns Let me tell you, it smells like another day in the financial jungle where insiders might be feasting while the regular Joe shareholders are left nibbling on crumbs. Fulcrum Therapeutics, Weave Communications, and Bio-Techne are in the crosshairs for deals that may favor those on the inside track over you and me, the...

Continue Reading
ABC Honors 2026 Spirit of the Heart Leaders

Updated Category News Views 4

Celebrating Champions of Cardiovascular Health In a world where accolades often feel as cold as the stock market after a crash, it’s heartening to see genuine recognition for those who are making actual, lasting impact. On October 3, 2026, the Association of Black Cardiologists (ABC) will hold its annual Spirit of the Heart Awards at none other than Cipriani Wall...

Continue Reading
Global Communication Works Opens SignlLabs™ AI Licensing

Updated Category News Views 43

AI Signaling Moves Beyond GCW's Own Clients Remember when we first looked at GCW's SignlLabs and the idea of helping brands show up inside ChatGPT, Gemini, Claude, Copilot and Perplexity? Well, Global Communication Works is taking the next step. Instead of keeping its AI Signaling playbook inside the agency walls, GCW is now opening SignlLabs up for licensing

Continue Reading
CUBEX Lights Up Veterinary Care with Mini Essential

Updated Category News Views 5

Inventory Woes? Meet Mini Essential If you’ve ever worked in or around veterinary hospitals, you know the old-school headaches of managing controlled substances. Picture this: piles of paper logs, end-of-shift recounting, and inevitable discrepancies that rear their ugly heads long after closing time. Enter CUBEX, shaking things up with their latest launch, Mini...

Continue Reading
RevSystems Joins Elite OpenAI Partner Network

Updated Category News Views 3

RevSystems Inks Deal with OpenAI Partner Network In the latest shuffle of the AI advisory deck, RevSystems just found itself elbowing into the exclusive OpenAI Partner Network. Based out of New York, RevSystems has carved a niche by spinning tech wizardry into tangible business results. Their new status as an OpenAI Select Partner puts them on a playing field where AI...

Continue Reading
Health Net's $2M Boost for Stanislaus Affordable Housing

Updated Category News Views 3

Joining the Fight Against California’s Housing Crisis Well, I'll be the first to say it's a breath of fresh air when a healthcare beast like Health Net starts investing in something as critical as affordable housing. This is no drop in the bucket—two million dollars is quite the commitment to fix some of the mess that’s been brewing in Stanislaus County, California....

Continue Reading

Top 5 Most Recently Viewed Articles

Incline Equity Partners Secures Significant Funds for Growth

Updated Category News Views 388

Incline Equity Partners Closes Major Funding Round Incline Equity Partners, a prominent player in the private equity landscape, has successfully closed an oversubscribed continuation vehicle for Accredited Labs, achieving around $300 million in commitments. This funding round is seen as a significant endorsement from Incline's partners and employees, reflecting their...

Continue Reading
Legal Experts Challenge National Electric Works Over Wage Issues

Updated Category News Views 119

Legal Experts Challenge Wage Practices at National Electric Works A recent lawsuit has brought to light serious concerns regarding National Electric Works Incorporated and its alleged violations of California labor laws related to wage payments. Attorneys from Zakay Law Group, APLC, and JCL Law Firm, APC, are taking a stand against what they say are unlawful employment...

Continue Reading
Significant Growth Ahead for Flock Adhesives Market

Updated Category News Views 103

Growth Projections for the Flock Adhesives Market The flock adhesives market is on a promising trajectory, anticipated to expand from US$ 2,697.8 million in 2024 to an impressive US$ 4,696.4 million by 2034. According to recent studies, a robust compound annual growth rate (CAGR) of 5.7% is projected throughout this growth period. Benefits of Polyurethane Flock Adhesives...

Continue Reading
Strategic Investment Elevates HOPE Therapeutics for Growth

Updated Category News Views 155

Exciting Developments at HOPE Therapeutics, Inc. HOPE Therapeutics, Inc., a notable player in interventional psychiatry, has reached a significant milestone with a recent strategic investment announcement. This move is aimed primarily at kickstarting a dedicated network of clinics designed to address severe mental health conditions, including suicidal depression and PTSD....

Continue Reading
Enhancing Property Management: JLL's Innovative AI Solution

Updated Category News Views 242

Revolutionizing Property Management with AI JLL has taken a significant step towards revolutionizing property management with the introduction of Prism AI. This powerful tool incorporates advanced artificial intelligence capabilities into JLL's well-regarded building operations platform, Prism. With the right blend of predictive analytics and automated workflows, Prism AI...

Continue Reading